Provided by Tiger Trade Technology Pte. Ltd.

Illumina

243.12
+14.196.20%
Volume:1.48M
Turnover:358.08M
Market Cap:36.71B
PE:45.27
High:246.76
Open:233.85
Low:232.99
Close:228.93
52wk High:246.76
52wk Low:88.00
Shares:151.00M
Float Shares:149.05M
Volume Ratio:1.21
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.37
EPS(LYR):5.45
ROE:32.34%
ROA:8.67%
PB:12.94
PE(LYR):44.61

Loading ...

Illumina teams with IDT to offer DRAGEN-powered secondary analysis for oncology sequencing workflows

Reuters
·
Jun 01

Illumina Is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 01

Illumina Inc : Guggenheim Raises Target Price to $180 From $170

THOMSON REUTERS
·
Jun 01

Movement Alert|Illumina Rises 5.09% in Regular Trading, Launches Whole-Genome Cancer Residual Disease Detection Workflow

Market Focus
·
May 29

Stock Track | Illumina Soars 5.14% Intraday on Multiple Product Launches Including Whole-Genome Sequencing Workflow and FireflyGO Platform

Stock Track
·
May 29

Illumina, SPT Labtech launch fireflyGO automation platform for targeted oncology sequencing workflows

Reuters
·
May 29

Illumina and Spt Labtech Unveil Fireflygo, Enabling Faster, Simpler Targeted Oncology Research

THOMSON REUTERS
·
May 29

Illumina announces new complete solution for MRD research

TIPRANKS
·
May 28

Illumina Launches Whole Genome Cancer Research Workflow

MT Newswires Live
·
May 28

Illumina Introduces the First Distributed Whole-Genome Sequencing Solution for Highly Sensitive Mrd Research

THOMSON REUTERS
·
May 28

Inari appoints Flagship’s Ryan Rapp to board of directors

Reuters
·
May 27

Illumina Shareholders Back Board, Auditor and Executive Pay

TIPRANKS
·
May 27

Illumina shareholders approve Ernst & Young as independent auditor

Reuters
·
May 27

Illumina director David P. King files initial beneficial ownership statement

Reuters
·
May 23

David P. King Elected to Illumina's Board of Directors

THOMSON REUTERS
·
May 22

Press Release: David P. King elected to Illumina's Board of Directors

Dow Jones
·
May 22

Illumina Earnings Call Signals Confident Clinical Pivot

TIPRANKS
·
May 20

Illumina releases 2025 Corporate Responsibility Report highlighting genomics access efforts

Reuters
·
May 20

Illumina Releases 2025 Corporate Responsibility Report, Expanding Access to Genomics and Accelerating Global Impact

THOMSON REUTERS
·
May 20

Illumina's Mid-Teens Clinical Growth Appears Sustainable Over Next 1 to 2 Years, RBC Says

MT Newswires Live
·
May 16